Frid, Petrea http://orcid.org/0000-0003-1452-2064
,
Drake, Mattias
Giese, A. K.
Wasselius, J.
Schirmer, M. D.
Donahue, K. L.
Cloonan, L.
Irie, R.
Bouts, M. J. R. J.
McIntosh, E. C.
Mocking, S. J. T.
Dalca, A. V.
Sridharan, R.
Xu, H.
Giralt-Steinhauer, E.
Holmegaard, L.
Jood, K.
Roquer, J.
Cole, J. W.
McArdle, P. F.
Broderick, J. P.
Jimenez-Conde, J.
Jern, C.
Kissela, B. M.
Kleindorfer, D. O.
Lemmens, R.
Meschia, J. F.
Rundek, T.
Sacco, R. L.
Schmidt, R.
Sharma, P.
Slowik, A.
Thijs, V.
Woo, D.
Worrall, B. B.
Kittner, S. J.
Mitchell, B. D.
Petersson, J.
Rosand, J.
Golland, P.
Wu, O.
Rost, N. S.
Lindgren, A.
Funding for this research was provided by:
Hjärt-Lungfonden (20160316)
Vetenskapsrådet (2018-02543)
Ministerio de Sanidad y Consumo (RD12/0042/0020)
National Institute of Neurological Disorders and Stroke (NINDS U01 NS080168, R01NS100178, R01NS105150, R01NS100178, R01NS100178, R01NS086905, R01 NS086905)
National Institute of Biomedical Imaging and Bioengineering (P41EB015902)
Article History
Received: 4 September 2019
Revised: 28 October 2019
Accepted: 30 October 2019
First Online: 11 November 2019
Compliance with ethical standards
:
: PF, MD, AKG, JW, MDS, KLD, LC, RI, MJRJB, ECM, AVD, RS, HX, EGS, LH, KJ, J Roquer, JWC, PFMA, JPB, JJC, CJ, BMK, DOK, RL, JFM, TR, RLS, RS, PS, AS, DW, BBW, SJK, BDM, PG, and JP: None. SJTM reports personal fees from Alphabet, Inc., outside the submitted work; VT reports grants from NINDS funding, during the conduct of the study; personal fees and non-financial support from Boehringer Ingelheim, personal fees from Pfizer, personal fees from Medtronic, personal fees from Amgen, personal fees from Bayer, outside the submitted work; J Rosand reports personal fees from Boehringer Ingelheim, Pfizer, and New Beta Innovations, outside the submitted work; OW reports grants from NIH-NINDS, during the conduct of the study; personal fees from Penumbra, Inc and Genentech, outside the submitted work; NSR reports grants from National Institutes of Health, during the conduct of the study; AL reports personal fees from Bayer, BMS/Pfizer, Astra Zeneca, and Boehringer Ingelheim, outside the submitted work.